Background: The liver is a well-known player in the metabolism and removal of drugs. Drug
metabolizing enzymes in the liver detoxify drugs and xenobiotics, ultimately leading to the …

Chronic liver disease (CLD) affects a significant portion of the global population, leading to a
substantial number of deaths each year. Distinct forms like non-alcoholic fatty liver disease …

Investigating the genetic underpinnings of human aging is essential for unraveling the
etiology of and developing actionable therapies for chronic diseases. Here, we characterize …

Consumer demand for healthy snack products has led to increased efforts to modify
glycemic responses of these products. The formation of starch-ferulic acid (FA) complexes …

Nonalcoholic steatohepatitis (NASH) is a severe liver metabolic disorder, however, there are
still no effective and safe drugs for its treatment. Previous clinical trials used various …

Hispanics of Mexican descent have disproportionate rates of non-alcoholic fatty liver
disease (NAFLD). The purpose of this work is to investigate the association between the …

Aim To examine the associations of a diet high in flavonoid-rich foods, as reflected by a
“Flavodiet Score”(FDS), the major individual food contributors to flavonoid intake, and …

In exploring nature's potential in addressing liver-related conditions, this study investigates
the therapeutic capabilities of flavonoids. Utilizing in silico methodologies, we focus on …

We previously found greater reduction of colon cancer (CC) biomarkers for red wheat
compared to white wheat regardless of refinement state. In the present study we examined …

This study estimated that the combined effect of γ-Oryzanol and N-acetylcysteine (NAC)
against high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) in rats also …